CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · IEX Real-Time Price · USD
2.510
+0.080 (3.29%)
At close: Apr 23, 2024, 4:00 PM
2.420
-0.090 (-3.59%)
After-hours: Apr 23, 2024, 7:56 PM EDT

CASI Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
33.8843.1130.1715.144.130000.050.02
Upgrade
Revenue Growth (YoY)
-21.41%42.89%99.25%266.52%----101.09%-
Upgrade
Cost of Revenue
13.8315.8312.569.513.940000.010.01
Upgrade
Gross Profit
20.0527.2817.615.630.20000.040.02
Upgrade
Selling, General & Admin
41.8437.7838.4127.4830.44183.164.783.123.76
Upgrade
Research & Development
9.861614.4211.479.348.517.64.654.082.77
Upgrade
Other Operating Expenses
-6.3710.786.6218.217.380.6900019.68
Upgrade
Operating Expenses
45.3364.5559.4557.1647.1527.1910.759.427.1926.2
Upgrade
Operating Income
-25.28-37.27-41.84-51.53-46.96-27.19-10.75-9.42-7.15-26.19
Upgrade
Interest Expense / Income
00000000.030.080.03
Upgrade
Other Expense / Income
1.741.76-5.18-3.24-0.930.280.020.01-0.03-0.01
Upgrade
Pretax Income
-27.02-39.03-36.65-48.29-46.03-27.47-10.77-9.45-7.21-26.2
Upgrade
Income Tax
-0.081.9800000000
Upgrade
Net Income
-26.94-41.01-36.65-48.29-46.03-27.47-10.77-9.45-7.21-26.2
Upgrade
Preferred Dividends
0.02000000000
Upgrade
Net Income Common
-26.96-41.01-36.65-48.29-46.03-27.47-10.77-9.45-7.21-26.2
Upgrade
Shares Outstanding (Basic)
131414111086633
Upgrade
Shares Outstanding (Diluted)
131414111086633
Upgrade
Shares Change
-2.10%0.27%23.23%15.12%13.21%37.78%10.10%72.19%13.47%9.45%
Upgrade
EPS (Basic)
-2.02-3.01-2.69-4.37-4.80-3.20-1.80-1.70-2.20-9.20
Upgrade
EPS (Diluted)
-2.02-3.01-2.69-4.37-4.80-3.20-1.80-1.70-2.20-9.20
Upgrade
Free Cash Flow
-22.21-26.56-35.78-24.69-30.3-29.71-7.34-6.09-5.54-4.23
Upgrade
Free Cash Flow Per Share
-1.66-1.95-2.63-2.23-3.16-3.51-1.19-1.09-1.71-1.48
Upgrade
Gross Margin
59.19%63.28%58.38%37.20%4.74%---86.85%68.53%
Upgrade
Operating Margin
-74.62%-86.47%-138.68%-340.31%-1136.72%----14990.78%-110370.00%
Upgrade
Profit Margin
-79.58%-95.14%-121.50%-318.92%-1114.31%----15104.01%-110432.45%
Upgrade
Free Cash Flow Margin
-65.55%-61.62%-118.59%-163.03%-733.38%----11608.83%-17816.18%
Upgrade
EBITDA
-22.29-35.42-33.56-45.06-43.46-25.8-10.65-9.36-7.06-26.13
Upgrade
EBITDA Margin
-65.79%-82.17%-111.24%-297.58%-1051.92%----14789.80%-110117.37%
Upgrade
Depreciation & Amortization
4.733.613.13.232.581.670.120.070.070.05
Upgrade
EBIT
-27.02-39.03-36.65-48.29-46.03-27.47-10.77-9.43-7.12-26.18
Upgrade
EBIT Margin
-79.75%-90.55%-121.50%-318.92%-1114.31%----14933.12%-110320.42%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).